A cocaine vaccine, currently under investigation by several laboratories, would be an innovative and exciting means of treating and preventing cocaine addiction.
However, an approved vaccine will raise at least two major areas of concern. (I) Loss of privacy :
cocaine antibodies might be used as a marker to identify, penalize, and stigmatize vaccinated individuals. (2) Selection for vaccination : should immunization be voluntary or compelled ;
should immunization be restricted to addicts, to those at risk of addiction, or should it be universal ;
should immunization be used in children ?
I propose to analogize cocaine addiction to an infectious disease which poses a major public health problem.
This approach can provide an ethical and legal foundation on which we may begin to formulate a societal approach to the use of the cocaine vaccine.
Mots-clés Pascal : Cocaïne, Toxicomanie, Homme, Traitement, Immunothérapie, Vaccin, Anticorps, Marqueur biologique, Ethique, Confidentialité, Législation
Mots-clés Pascal anglais : Cocaine, Drug addiction, Human, Treatment, Immunotherapy, Vaccine, Antibody, Biological marker, Ethics, Confidentiality, Legislation
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 98-0092462
Code Inist : 002B03D. Création : 14/05/1998.